0000950170-24-066826.txt : 20240530 0000950170-24-066826.hdr.sgml : 20240530 20240530180914 ACCESSION NUMBER: 0000950170-24-066826 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240522 FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kowieski Mark CENTRAL INDEX KEY: 0002024869 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36075 FILM NUMBER: 241006987 MAIL ADDRESS: STREET 1: C/O EVOKE PHARMA, INC. STREET 2: 420 STEVENS AVENUE, SUITE 370 CITY: SOLANA BEACH STATE: CA ZIP: 92075 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 370 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 370 CITY: SOLANA BEACH STATE: CA ZIP: 92075 3 1 ownership.xml 3 X0206 3 2024-05-22 0 0001403708 Evoke Pharma Inc EVOK 0002024869 Kowieski Mark C/O EVOKE PHARMA, INC. 420 STEVENS AVENUE, SUITE 230 SOLANA BEACH CA 92075 false true false false Chief Financial Officer Common Stock 5000 I By IRA Stock Option (Right to Buy) 2.09 2032-06-12 Common Stock 16000 D Stock Option (Right to Buy) 4.01 2033-02-07 Common Stock 7500 D The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of June 13, 2022, subject to the reporting person's continuous service to the issuer on each such vesting date. The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2023, subject to the reporting person's continuous service to the issuer on each such vesting date. /s/ Mark Kowieski 2024-05-30